As of October 27, 2026, Lunai Bioworks Inc. is a publicly traded company (Nasdaq: LNAI); its largest reported holder is Laksya Ventures Inc., with 9.6% on Schedule 13G of September 26, 2025, then Hansen Hans Christian (9.4%). The largest insider holding is William Anderson Wittekind, a 10% owner, with 18,133,196 shares, per Form 4 of March 12, 2025 (Schedule 13G, September 26, 2025).
About to sign with, pay or invest in Lunai Bioworks Inc.? See the free Snapshot first.
Free to see. No signup.
Is Lunai Bioworks Inc. a real, registered company?
- Lunai Bioworks Inc. files with the SEC under CIK 1527728 (its SEC filings).
- Its shares are listed under the ticker LNAI on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Suite 906 Los Angeles, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under RENOVARO INC. in our court records and SEC 8-K records (as of 2026-10-27).
- Leadership changes: the latest reported is Nathen Fuentes, Chief Financial Officer (Form 8-K filed 2026-10-23). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Hansen Hans Christian (filed 2026-07-17).
Who are Lunai Bioworks Inc.'s owners and officers?
Lunai Bioworks Inc.: incorporated in Delaware; business address in Suite 906 Los Angeles, California; industry Pharmaceutical Preparations (Form D, 2026-10-23).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Executive Officer (Form D, 2024-02-23)
- : Executive Officer (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
- : Director (Form D, 2024-02-23)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-15 | William Anderson Wittekind | 4.5% |
| Schedule 13G, 2026-07-17 | Hansen Hans Christian | 9.4% |
| Schedule 13D/A, 2025-12-09 | William Anderson Wittekind | 6.8% |
| Schedule 13D/A, 2025-11-28 | William Anderson Wittekind | 6.8% |
| Schedule 13D/A, 2025-11-12 | William Anderson Wittekind | 7.8% |
| Schedule 13G, 2025-09-26 | Laksya Ventures Inc. | 9.6% |
| Schedule 13D/A, 2025-07-10 | William Anderson Wittekind | 8% |
Want the whole picture on Lunai Bioworks Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lunai Bioworks Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lunai Bioworks Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-23 | Nathen Fuentes | Chief Financial Officer | departed | |
| Form 8-K, 2026-10-23 | Douglas W. Calder | Director | departed |
Which insiders own Lunai Bioworks Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 18,133,196 shares, 3,353,878 held directly and 14,779,318 indirectly (Form 4, 2025-03-12).
- , the chief executive and a director: 250,000 shares (5.0% of shares outstanding) (Form 4, 2024-10-29).
- , a director: 250,000 shares (5.0% of shares outstanding) (Form 4, 2025-02-25).
Shares outstanding: 5,034,452 as of 2026-10-13, from the company's latest SEC cover page.
How much has Lunai Bioworks Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-02-23 | $106.85M | $106.85M |
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-05-01).
Keep reading
More on Lunai Bioworks Inc. and the records around it.
Lunai Bioworks Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/lunai-bioworks